QuidelOrtho Announces New R&D Executive Leader
Jonathan Siegrist, EVP of R&D and CTO, QuidelOrtho (Photo: Business Wire) Jonathan Siegrist appointed as EVP of R&D and CTO SAN DIEGO, October 09, 2024–(BUSINESS WIRE)–QuidelOrtho Corporation (Nasdaq: QDEL), a…
Novavax Names Dr. Ruxandra Draghia-Akli as New Executive Vice President and Head of Research & Development
Classified in: Ebola virus, Health, Covid-19 virusSubject: PER Ruxandra Draghia-Akli, MD, PhD brings more than 20 years of extensive clinical, corporate and global public health expertise to support Novavax’s transition…